Aurora kinase A (AURKA) has been shown to facilitate HSC activation and liver fibrosis through the Wnt/β-catenin pathway, suggesting a potential therapeutic target for fibrosis management.62 The gene discussed is AURKA; the disease is Hepatic fibrosis.